20012017
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Prof Mills is an internationally-respected physician, scientist and businessman. In addition to his Emeritus Professorship at Monash University he holds professorial positions at RMIT and the University of California, San Francisco (UCSF). He is the Director of Research and Development at TissuPath Specialist Pathology, a Consulting Physician at The Alfred Hospital, Chairman of the Research Program and Research Advisory Committee of the Prostate Cancer Foundation of Australia (PCFA) and a non-executive director of GBS Venture Partners Pty Ltd.

His past academic appointments were at Howard University in the USA and the University of Melbourne. From 1976 to 1992 he was Chief of Infectious Diseases at UCSF based at San Francisco General Hospital where he played an important role in the UCSF and US response to the AIDS epidemic as Principal Investigator of the UCSF AIDS Clinical Trial Group (ACTG) from 1985-1992 and Chairman of the ACTG Opportunistic Infection Committee from 1986-1990.

From from 1992 to 2002 he was (Managing) Director of the Burnet Institute; amongst his achievements there was the founding of AAMRI, the Association of Australian Medical Research Institutes, the peak body representing medical research institutes and now including over 40 members.

His research interests have included bacterial endocarditis, altitude sickness, viral infections including influenza, respiratory syncytial virus, herpes simplex virus, cytomegalovirus and HIV (human immunodeficiency virus), and prostate cancer.

His past business experience includes non-executive director positions at three ASX-listed companies, AMRAD Corporation, Phosphagenics Limited and Narhex Life Sciences; he was Chairman of AMRAD for 8 months and Deputy Chair for 2 years, Managing Director of Narhex Life Sciences for 2andfrac12; years, and Executive Chairman of a Swedish company, Cavidi AB, for 6 years.

He has co-authored 197 peer-reviewed publications reporting original data, 96 'other' publications (e.g. editorials, reviews, letters), edited or co-authored 13 books and authored or co-authored 95 book chapters.

 

Related Links:

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2005 2006

Research Output 2001 2017

Listeria monocytogenes peritonitis in an HIVinfected patient

Sia, C., Wilson, S., Ananda-Rajah, M., Mills, J. & Aung, A. K., 1 May 2017, In : Clinical Nephrology. 87, 5, p. 267-270 4 p.

Research output: Contribution to journalArticleOtherpeer-review

Refractory raoultella planticola peritonitis in an HIV positive patient

Sia, C. SB., Wilson, S., Ananda-Rajah, M., Mills, J. & Aung, A. K., 11 Oct 2016, In : Nephrology. 21, 11, p. 979-980 2 p.

Research output: Contribution to journalLetterOtherpeer-review

Assessing expression of MUC1 and ZAG protein biomarkers in prostate biopsies improves prediction of adverse pathology following radical prostatectomy

Durrani, N., Waldron, M., Cherry, C., Harewood, L., Frydenberg, M., Pedersen, J. & Mills, J., 2015, In : The Open Prostate Cancer Journal. 8, 1, p. 1-9 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Quantitative assessment of intra-patient variation in CD4+ T cell counts in stable, virologically-suppressed, HIV-infected subjects

Gordon, C., Cheng, A. C-S., Cameron, P. U., Bailey, M. J., Crowe, S. M. & Mills, J., 2015, In : PLoS ONE. 10, 6, 10 p., e0125248.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

A three-protein biomarker panel assessed in diagnostic tissue predicts death from prostate cancer for men with localized disease

Severi, G., Fitzgerald, L. M., Muller, D. C., Pedersen, J., Longano, A., Southey, M. C., Hopper, J. L., English, D. R., Giles, G. G. & Mills, J., 1 Oct 2014, In : Cancer Biology and Medicine. 3, 5, p. 1266-1274 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File